Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals-Reference-Cited by-同舟云学术

Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals

Published:2023-02-01 Issue:50 Volume:62 Page:20567-20581
ISSN:0020-1669
Container-title:Inorganic Chemistry
language:en
Short-container-title:Inorg. Chem.

Author:

Phipps Michael D.¹²³⁴,Cingoranelli Shelbie⁵,Bhupathiraju N. V. S. Dinesh K.²^ORCID,Younes Ali²^ORCID,Cao Minhua²,Sanders Vanessa A.⁶,Neary Michelle C.²^ORCID,Devany Matthew H.²,Cutler Cathy S.⁶,Lopez Gustavo E.¹³^ORCID,Saini Shefali⁵,Parker Candace C.⁵^ORCID,Fernandez Solana R.⁵,Lewis Jason S.⁴^ORCID,Lapi Suzanne E.⁵,Francesconi Lynn C.¹²^ORCID,Deri Melissa A.¹³^ORCID

Affiliation:

1. Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, New York10016, United States

2. Department of Chemistry, City University of New York Hunter College, 695 Park Avenue, New York, New York10065, United States

3. Department of Chemistry, Lehman College of the City University of New York, Bronx, New York10468, United States

4. Program in Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, New York, New York10065, United States

5. Department of Radiology, University of Alabama at Birmingham (UAB), Birmingham, Alabama35294, United States

6. Medical Isotope Research and Production Laboratory, Collider−Accelerator Division, Brookhaven National Laboratory (BNL), Upton, New York11973, United States

Funder

Tow Foundation

Hunter College

U.S. Department of Energy

National Institute of General Medical Sciences

National Institutes of Health

National Science Foundation

Publisher

American Chemical Society (ACS)

Subject

Inorganic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.inorgchem.2c03931

Reference50 articles.

1. FDA-approved radiopharmaceuticals 2022. https://www.cardinalhealth.com/content/dam/corp/web/documents/fact-sheet/cardinal-health-fda-approved-radiopharmaceuticals.pdf (accessed 10/19/2022).

2. Information extracted from the NuDat Database, National Nuclear Data Center, 2021.

3. Promising Prospects for 44Sc-/47Sc-Based Theragnostics: Application of 47Sc for Radionuclide Tumor Therapy in Mice

4. Scandium(iii) complexes of monophosphorus acid DOTA analogues: a thermodynamic and radiolabelling study with 44Sc from cyclotron and from a 44Ti/44Sc generator

5. 44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross section measurements for the production of 49,51Cr and 47Sc from proton irradiation of natural vanadium up to 24 MeV;Applied Radiation and Isotopes;2024-10

2. Development of a SnO2-based 44Ti/44Sc generator for medical applications;Journal of Chromatography A;2024-09

3. Improving the In Vivo Stability of [⁵²Mn]Mn(II) Complexes with 18-Membered Macrocyclic Chelators for PET Imaging;Journal of Medicinal Chemistry;2024-06-27

4. Preparation of HOPO-containing lariate ethers based on the diaza-18-crown-6 scaffold;Chemical Papers;2024-03-14

5. PYTA: a universal chelator for advancing the theranostic palette of nuclear medicine;Chemical Science;2024